How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Business Services · Forecast 2027–2033
Biological Fermentation System Market
- By Fermentation Type: Batch Fermentation, Fed-Batch Fermentation, Continuous Fermentation, Solid-State Fermentation
- By Microorganism Type: Bacteria, Yeast, Fungi, Algae
- By End-Use Industry: Pharmaceuticals, Food & Beverage, Biofuels, Agriculture, Wastewater Treatment
- By System Configuration: Stirred Tank Bioreactors, Airlift Bioreactors, Packed Bed Bioreactors, Membrane Bioreactors
- By Scale of Operation: Laboratory Scale, Pilot Scale, Industrial Scale
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Batch Fermentation leads By Fermentation Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 14 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 291 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.177 →
- 12 Company Profiles 14 players: SWOT & benchmarking p.185 →
Full report · locked preview
Everything inside the Biological Fermentation System Market report
A complete, evidence-based study - 12 chapters and 122 sections covering market size, segmentation across 5 axes, regional analysis and 14 company profiles, forecast to 2033.
Segmentation covered
Fermentation Type 4
Microorganism Type 4
End-Use Industry 5
System Configuration 4
Scale of Operation 3
Companies profiled
Eppendorf AG
Sartorius AG
Thermo Fisher Scientific Inc.
Merck KGaA (MilliporeSigma)
GE Healthcare Life Sciences (Cytiva)
Applikon Biotechnology
Pall Corporation
Bio-Rad Laboratories Inc.
Danaher Corporation
Agilent Technologies Inc.
PBS Biotech
Infors HT
+2 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
14 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Eppendorf AG
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Sartorius AG
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Thermo Fisher Scientific Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Merck KGaA (MilliporeSigma)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →GE Healthcare Life Sciences (Cytiva)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Applikon Biotechnology
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Pall Corporation
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Bio-Rad Laboratories Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Danaher Corporation
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Agilent Technologies Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →PBS Biotech
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Infors HT
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.220 →Tecan Group Ltd.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →New Brunswick Scientific (Eppendorf)
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →
Global · 2025–2033
$2,042M by 2033 · 3.6% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Batch Fermentation51.6
- Fed-Batch Fermentation14.7
- Continuous Fermentation19.4
- Solid-State Fermentation14.3
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$506.2M → $670.0M · 3.6%
Europe$352.8M → $488.1M · 4.1%
Asia Pacific$322.1M → $413.6M · 3.2%
Latin America$199.4M → $296.5M · 5.1%
Middle East and Africa$153.4M → $210.7M · 4.0%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →3.592026
3.602027
3.622028
3.622029
3.652030
3.652031
3.672032
3.672033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Eppendorf AG20.1
- Sartorius AG22.8
- Thermo Fisher Scientific Inc.8.2
- Merck KGaA (MilliporeSigma)6.1
- GE Healthcare Life Sciences (Cytiva)6.5
- Applikon Biotechnology8.4
- Others27.9
Segment contribution to growth (%)
Fig. 18 · p.39 →Fermentation Type11.2%
Microorganism Type24.3%
End-Use Industry21.7%
System Configuration19.8%
Scale of Operation23.1%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America32.2
- Europe23.5
- Asia Pacific19.9
- Latin America14.3
- Middle East and Africa10.1
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Eppendorf AG | 90 | 97 | 75 | 97 | 82 | 91 | 89 |
| Sartorius AG | 90 | 70 | 74 | 86 | 79 | 85 | 81 |
| Thermo Fisher Scientific Inc. | 87 | 65 | 72 | 83 | 87 | 68 | 77 |
| Merck KGaA (MilliporeSigma) | 82 | 74 | 69 | 80 | 59 | 65 | 72 |
| GE Healthcare Life Sciences (Cytiva) | 54 | 57 | 64 | 51 | 57 | 53 | 56 |
| Applikon Biotechnology | 51 | 57 | 67 | 55 | 62 | 68 | 60 |
| Pall Corporation | 44 | 51 | 52 | 44 | 49 | 63 | 51 |
| Bio-Rad Laboratories Inc. | 43 | 49 | 57 | 37 | 60 | 43 | 48 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Eppendorf AG
- Sartorius AG
- Thermo Fisher Scientific Inc.
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Eppendorf AG | ✓ | ✓ | ✓ | ◐ | ✓ | ✓ |
| Sartorius AG | ✓ | ◐ | ✓ | ✓ | ◐ | ✓ |
| Thermo Fisher Scientific Inc. | ✓ | ◐ | ◐ | ✓ | ◐ | ◐ |
| Merck KGaA (MilliporeSigma) | ✓ | ✓ | − | ◐ | ◐ | − |
| GE Healthcare Life Sciences (Cytiva) | ◐ | − | ◐ | ◐ | ◐ | ◐ |
| Applikon Biotechnology | − | ◐ | ✓ | ◐ | − | ✓ |
| Pall Corporation | − | − | ◐ | ◐ | − | ◐ |
| Bio-Rad Laboratories Inc. | − | − | − | ◐ | − | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Eppendorf AG89
2Sartorius AG81
3Thermo Fisher Scientific Inc.77
4Merck KGaA (MilliporeSigma)72
5Applikon Biotechnology60
6GE Healthcare Life Sciences (Cytiva)56
7Pall Corporation51
8Bio-Rad Laboratories Inc.48
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
Eppendorf AGSartorius AG
Challenger2
Strong scale, closing on the leaders.
Thermo Fisher Scientific Inc.Merck KGaA (MilliporeSigma)
Contender1
Focused players with pockets of strength.
Applikon Biotechnology
Niche3
Specialists in a single segment or region.
GE Healthcare Life Sciences (Cytiva)Pall CorporationBio-Rad Laboratories Inc.
Go-to-market strategy
Land Fermentation Type in North America, then scale across Biological Fermentation System Market — a $66M beachhead inside a $1.10B market.
Beachhead (SOM)$66Mobtainable near-term
Serviceable (SAM)$407Mreachable market
Primary motionPartner-led + digitalgo-to-market
Time to scale4 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion90 fit
Batch Fermentation
Best fit — highest urgency & budget in Fermentation Type.
Economic buyer79 fit
Fed-Batch Fermentation
Strong fit — clear ROI and a fast path to value.
End user69 fit
Continuous Fermentation
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Fermentation Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Microorganism Type & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + End-Use Industry
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales47%
Partner / channel28%
Digital / self-serve19%
Marketplaces7%
Positioning & messaging
§GTM 2 · p.194 →For Fermentation Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Biological Fermentation System Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified45%
Sales qualified21%
Evaluation13%
Closed-won6%
$12.0KCAC
$71KLTV
5.9:1LTV : CAC
< 3 moCAC payback
Investment thesis
Biological Fermentation System Market is a durable-growth opportunity — $4.28B by 2033, compounding at 6.9%.
TAM · 2025$2.50Btoday
TAM · 2033$4.28Bforecast
CAGR6.9%2027–2033
Cumulative$29.9Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$4.28BTotal addressable market
SAM$1.59BServiceable available market
SOM$330MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →6.9% CAGR
Demand compounds through 2033, outpacing GDP across Fermentation Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Fermentation Type moving from early to mainstream — durable secular demand.
Consolidation upside
14+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$4.28BLarge & growingTAM by 2033 at 6.9% CAGR
$1.59BServiceable nowreachable with today’s model
$330MBeachhead winobtainable near-term share
14+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$3.34BBear4.5% CAGR
$4.28BBase6.9% CAGR
$5.47BBull9.2% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Microorganism Type optionality
- Customer concentrationBroaden installed base beyond top accounts
Board pack · executive summary
Biological Fermentation System Market — a $1.65B market by 2033. Plan: grow share from 7.6% to 13.9%.
Market size · 2033$1.65Btotal addressable
Market CAGR5.4%2027–2033
Target share13.9%from 7.6% today
Revenue ambition$229Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 7.6% | 13.9% | At risk |
| Revenue | $127M | $229M | Behind |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | On track |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | Ahead |
| Gross margin | 28.6% | 40.5% | Behind |
| Customer retention | 87.0% | 96.0% | At risk |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Fermentation Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Microorganism Type capability
A defensible second engine — invest in Microorganism Type to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Fermentation Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Microorganism Type
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $29M capacity & capability investment
- Greenlight bolt-on M&A in Microorganism Type
- Authorise North America expansion plan
- Fund R&D program for Fermentation Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownOn track
- Competitive share lossOn track
- Input-cost & supply riskAt risk
- Regulatory / policy changeOn track
- Execution & talentOn track
Sales deck · value proposition
Win the Biological Fermentation System Market conversation — a $8.08B market you can size, segment and defend in minutes.
Market size · 2033$8.08Btotal opportunity
Growth5.0%CAGR to 2033
Addressable buyers1,252+accounts in scope
Typical ROI6×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Fermentation Type
Goal Grow share in Fermentation Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →6×return on cost, year one
< 3 mopayback period
$46K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
14+players profiled in this market
Coverage includes
Eppendorf AGSartorius AGThermo Fisher Scientific Inc.Merck KGaA (MilliporeSigma)GE Healthcare Life Sciences (Cytiva)Applikon BiotechnologyPall CorporationBio-Rad Laboratories Inc.+6 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Biological Fermentation System Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Biological Fermentation System Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Business Services · scroll →Biological Fermentation Tank Market
Market size, share, segmentation and regional forecast.
$5.2B market · 2025 base year
View reportBiological Fertilizer Fungicide Market
Market size, share, segmentation and regional forecast.
$5.0B market · 2025 base year
View reportBiological Glue Market
Market size, share, segmentation and regional forecast.
$3.6B market · 2025 base year
View reportBiological Heart Valve Market
Market size, share, segmentation and regional forecast.
$4.2B market · 2025 base year
View reportBiological Heart Valves Market
Market size, share, segmentation and regional forecast.
$3.6B market · 2025 base year
View reportBiological Ice Bag Market
Market size, share, segmentation and regional forecast.
$477M market · 2025 base year
View reportBiological Indicator Incubator Market
Market size, share, segmentation and regional forecast.
$4.7B market · 2025 base year
View reportBiological Indicator Market
Market size, share, segmentation and regional forecast.
$5.6B market · 2025 base year
View reportBiological Integrated Circuit Market
Market size, share, segmentation and regional forecast.
$4.2B market · 2025 base year
View reportBiological Microscope Market
Market size, share, segmentation and regional forecast.
$2.7B market · 2025 base year
View reportBiological Naphtha Market
Market size, share, segmentation and regional forecast.
$1.8B market · 2025 base year
View reportBiological Nerve Chip Market
Market size, share, segmentation and regional forecast.
$2.8B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report ships as a formatted PDF, a fully editable XLSX containing all underlying data tables, and a presentation-ready PPT deck - so you can re-chart, re-model, or drop any figure straight into your own deck.